Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Seaway Pharma Inc.
FDA Inspection
•Seaway Pharma Inc.•June 18, 2025

Seaway Pharma Inc. – FDA Inspection, Jun 18, 2025

Record Details

This FDA Inspection record concerns Seaway Pharma Inc., with an inspection on June 18, 2025, issued by the New York District Office, covering human drugs.

Company
Seaway Pharma Inc.
Inspection Date
June 18, 2025
Product Type
Human Drugs
Office
New York District Office
People
  • Edmund F. Mrak (FDA Associated Person)
  • Ifechimere I. Okafor (Company Rep)
View Company Profile

ID · ed914a53-d246-4b5f-8547-16c7b4be72d3

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1272511
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued, view the record

FDA Citations

11
  1. 21 CFR 211.56(a)Sanitation--buildings not clean, free of infestation
  2. 21 CFR 211.165(b)Microbiological testing
  3. 21 CFR 211.160(a)Following/documenting laboratory controls
  4. 21 CFR 211.194(a)(4)Complete Test Data
  5. 21 CFR 211.67(b)(3)Cleaning SOPs/instructions
  6. 21 CFR 211.165(a)Testing and release for distribution
  7. 21 CFR 211.84(d)(1)Identity Testing of Each Component
  8. 21 CFR 211.192Investigations of discrepancies, failures
  9. 21 CFR 211.22(d)Procedures not in writing, fully followed
  10. 21 CFR 211.166(a)Written program not followed

Showing 10 of 11 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Seaway Pharma Inc.

7
DateClassificationOfficeProject area
July 25, 2024NAICenter for Food Safety and Applied NutritionFood Composition, Standards, Labeling and Econ
September 21, 2023OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
September 15, 2021OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
July 25, 2019VAICenter for Food Safety and Applied NutritionFood Composition, Standards, Labeling and Econ
December 10, 2018OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 7 other inspections on the company page
Other documents for Seaway Pharma Inc.
  • FDA Inspection 1234892 - 2024-07-25
  • FDA Inspection 1220786 - 2023-09-21
  • FDA Inspection 1151771 - 2021-09-15
  • FDA Inspection 1097845 - 2019-07-25
  • FDA Inspection 1075781 - 2018-12-10

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Seaway Pharma Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.